ArticleJournal of sports science & medicine2016
Limitations of Spectral Electromyogramic Analysis to Determine the Onset of Neuromuscular Fatigue Threshold during Incremental Ergometer Cycling.
Article in Journal of sports science & medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recently, a new method has been proposed to detect the onset of neuromuscular fatigue during an incremental cycling test by assessing the changes in spectral electromyographic (sEMG) frequencies within individual exercise periods of the test. The method consists on determining the highest power output that can be sustained without a significant decrease in spectral frequencies. This study evaluated the validity of the new approach by assessing the changes in spectral indicators both throughout the whole test and within individual exercise periods of the test. Fourteen cyclists performed incremental cycle ergometer rides to exhaustion with bipolar surface EMG signals recorded from the vastus lateralis. The mean and median frequencies (Fmean and Fmedian, respectively) of the sEMG power spectrum were calculated. The main findings were: (1) Examination of spectral indicators within individual exercise periods of the test showed that neither Fmean nor Fmedian decreased significantly during the last (most fatiguing) exercise periods. (2) Examination of the whole incremental test showed that the behaviour of Fmean and Fmedian with increasing power output was highly inconsistent and varied greatly among subjects. (3) Over the whole incremental test, half of the participants exhibited a positive relation between spectral indicators and workload, whereas the other half demonstrated the opposite behavior. Collectively, these findings indicate that spectral sEMG indexes do not provide a reliable measure of the fatigue state of the muscle during an incremental cycling test. Moreover, it is concluded that it is not possible to determine the onset of neuromuscular fatigue during an incremental cycling test by examining spectral indicators within individual exercise periods of the test. Key pointsThe behaviour of spectral EMG indicators during the incremental test exhibited a high heterogeneity among individuals, with approximately half of the participants showing a positive relation between spectral indicators and workload and the other half showing the opposite behaviour.None of the spectral EMG indicators examined (Fmean nor Fmedian) decreased significantly between the ventilatory threshold and the highest power output.Examination of spectral indicators within individual exercise periods of the test showed that neither Fmean nor Fmedian decreased significantly during the last (most fatiguing) exercise periods.
Indexed as
Identifiers
26957938PMC4763834What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.